FDA Proposes Subscription Model to Prod Antibiotic Development

FDA Proposes Subscription Model to Prod Antibiotic Development

The US Food and Drug Administration (FDA) hopes to combat drug-resistant bacteria by introducing a four-pronged approach that includes a hospital “drug subscription” plan aimed at easing the costs and risks of developing new antimicrobials by pharmaceutical companies. The 5-year plan includes promoting antimicrobial stewardship, improving antimicrobial resistance surveillance, and improving regulatory science. Scott Gottlieb, […]

Industry News: How Has Big Pharma Been Tackling Drug Discovery Challenges?

Industry News: How Has Big Pharma Been Tackling Drug Discovery Challenges?

ELRIG organisers explain why they believe sharing and communicating the latest research and advances in technology is key to overcoming challenges in drug discovery A growing number of new molecules have been discovered that have led to the development of pioneering therapeutics for treating an extensive range of diseases. These blockbuster drugs have been used […]

What Is CBD and Why Do People Take It?

What Is CBD and Why Do People Take It?

CBD oil. (Credit: ELRoi/Shutterstock) One of the most controversial drugs in America can’t even get you high. Derived from marijuana, CBD, or cannabidiol, could help treat a range of medical conditions, early research suggests — but its Schedule I status has made it hard to study, leaving researchers and patients in the dark. Although it’s […]

One neat trick for forcing pharma to set lower drug prices

One neat trick for forcing pharma to set lower drug prices

Can a prescription drug simply cost too much for health insurance to cover? That idea is implicit in a new program by CVS Health, one of the largest pharmacy benefits managers (PBMs) in the country. The pros and the cons of the proposal were debated on Monday in Health Affairs, with pharmaceutical interests coming out […]

Your Daily Pharma Scoop: XBiotech Reports Positive Data, AstraZeneca's New Approval, Novartis' Positive MS Trial

Your Daily Pharma Scoop: XBiotech Reports Positive Data, AstraZeneca's New Approval, Novartis' Positive MS Trial

Stocks in News: XBIT, AZN XBiotech’s bermekimab shows positive effect in dermatitis pilot study XBiotech reported preliminary positive data from an open-label, dose escalation study of Phase 2 trial assessing its bermekimab candidate in moderate to severe atopic dermatitis (AD). On September 13, the share price climbed 28% pre-market on this apparently positive news. However, […]

Senate votes today on opioids and gag clauses

Senate votes today on opioids and gag clauses

With help from Brianna Ehley OPIOID WEEK: TAKE 2 — The Senate is set to vote late this afternoon on its massive opioid package, following a delay last week due to Hurricane Florence. The Senate is already working with the House to reconcile their differences so they can send a final version to the president’s […]

FDA Announces New Plan to Fight Antimicrobial Resistance

FDA Announces New Plan to Fight Antimicrobial Resistance

The US Food and Drug Administration (FDA) declared war on antimicrobial resistance (AMR) on September 14, announcing a comprehensive plan to combat arguably the biggest public health challenge facing the country. By now, of course, everyone working within the field of infectious diseases knows the much-discussed figures provided by the US Centers for Disease Control […]

Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Melvin R. Goodes Prize

Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Melvin R. Goodes Prize

NEW YORK, Sept. 17, 2018 /PRNewswire/ — Dr. Michela Gallagher has been named the recipient of the 2018 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. The prize, awarded by the Alzheimer’s Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer’s disease and related dementias. Dr. Gallagher, whose lifetime of research […]

AZ prepares to file COPD triple, taking on rival GSK

AZ prepares to file COPD triple, taking on rival GSK

AstraZeneca has said it is ready to file for approval of its chronic obstructive pulmonary disease (COPD) triple therapy before the end of the year, after publishing phase 3 data for the new drug. The KRONOS trial of PT010 – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled […]

New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients' Choices

New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients' Choices

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to treat cancer, rheumatoid arthritis, macular degeneration and other serious diseases. Under the new rules, these private Medicare insurance plans could require patients to try cheaper drugs first. If those are not effective, then the patients […]